
Progyny (PGNY) Stock Forecast & Price Target
Progyny (PGNY) Analyst Ratings
Bulls say
Progyny Inc. has experienced a significant 39% year-over-year increase in egg retrievals and banking, highlighting robust demand for its fertility services, particularly among women in the tech sector. The company is poised to capitalize on expanding revenue opportunities from the implementation of IVF mandates across more states and the launch of its fully-insured product offering, which is expected to provide incremental growth starting in FY27. Furthermore, with nearly 100% client retention and a growing number of covered lives gaining access to ancillary services—projected to rise from 1.5 million in 2025 to 2.7 million in 2026—Progyny showcases a strong business model and market position that supports a positive outlook.
Bears say
The financial outlook for Progyny Inc. is negative due to the potential impact of economic uncertainty and rising unemployment, which may dissuade employees from pursuing family building through the company's fertility benefit offerings. The company's adjusted EBITDA guidance has been lowered to a range of $224 to $239 million, falling short of both prior estimates and consensus expectations, reflecting challenges in revenue growth and market dynamics. Additionally, a decrease in projected covered lives from 7.6 million to 7.2 million signals a loss of client engagement in a competitive landscape, further exacerbating concerns about sustaining operational performance.
This aggregate rating is based on analysts' research of Progyny and is not a guaranteed prediction by Public.com or investment advice.
Progyny (PGNY) Analyst Forecast & Price Prediction
Start investing in Progyny (PGNY)
Order type
Buy in
Order amount
Est. shares
0 shares